<< Interleukin Genetics and Amway Global sign partnership agreement | Protox Therapeutics to present Phase 2 study data of PRX302 for benign prostatic hyperplasia >>
Read in | English | EspaƱol | Svenska

Reliv International net income down in 2009 third quarter

Published on October 29, 2009 at 7:50 AM · No Comments

Reliv International, Inc. (Nasdaq: RELV), a nutrition and direct selling company, today reported third-quarter net sales of $20.9 million vs. $23.9 million in the same quarter of 2008.

Net income was $324,000 vs. $536,000 in the 2008 third quarter, and earnings per diluted share were $0.03 compared to $0.04 in the same quarter last year.

In the United States, net sales totaled $18.3 million compared to $20.8 million in the third quarter of 2008. Net sales outside of the U.S. declined by approximately 14 percent. Excluding the impact of foreign currency fluctuations, however, the decline in foreign sales was about 5 percent.

Reliv also announced that it is reducing its dividend from $0.05 per share to $0.02 per share. For 2009, Reliv's annual dividend will be $0.07 rather than $0.10 per share.

"Despite the decline in our performance compared to last year's third quarter, we saw glimmers of light that we hope will shine brighter as we move into 2010," said Robert L. Montgomery, chairman, president and chief executive officer. "We achieved a five percent increase in the number of new distributors along with an increase in the number of orders this quarter over the third quarter of 2008," he said.

"This year we also reported a sequential increase in net sales from the second quarter to the third quarter for the first time since 2006," Montgomery said. "In addition, the number of orders and the size of the average order are up sequentially."

"The highlight of the third quarter was our international conference in St. Louis, where we introduced a new line of products under the Relivables name as well as a number of new business tools for distributors. All have been well received," Montgomery said.

For the first nine months of 2009, net sales totaled $64.7 million, down about 15 percent compared to the same period last year. U.S. sales decreased approximately 13 percent, while sales outside of the U.S. were down about 27 percent. Excluding foreign currency fluctuations, foreign sales were down 13.5 percent.

Net income for the first three quarters of this year equaled $1.7 million compared to $2.6 million for the first three quarters of 2008. Diluted earnings per share for the period equaled $0.13, down from diluted earnings per share of $0.17 for the first nine months of last year.

Reliv generated cash from operating activities of $4.8 million during the first nine months of 2009, an increase of approximately 34 percent over cash generated from operations during the same period last year. Reducing inventory levels was a key factor in the increase.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading